Skip to main content

Table 1 Association between A148T variants and selected types of cancer

From: Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

 

A148T

OR

95% Confidence Interval

p (adjusted p)

 

total controls (n = 3000)

105 (3.5%) G/A

     

bladder (n = 223)

0 (0%) A/A

7 (3.1%) G/A

0.9

0.4105-1.945

0.7764

(n.s)

colon (n = 724)

0 (0%) A/A

37 (5.1%) G/A

1.5

1.012-2.180

0.0423

(0.5499)

stomach (n = 246)

0 (0%) A/A

8 (3.3%) G/A

0.9

0.4461-1.925

0.8384

(n.s)

larynx (n = 396)

0 (0%) A/A

17 (4.3%) G/A

1.2

0.7326-2.088

0.4255

(n.s)

ovary (n = 340)

0 (0%) A/A

12 (3.5%) G/A

1.0

0.5491-1.853

0.9777

(n.s)

lung (n = 497)

0 (0%) A/A

34 (6.8%) G/A

2.0

1.358-3.018

0.0004

(0.0052)

prostate (n = 348)

0 (0%) A/A

13 (3.7%) G/A

1.1

0.5946-1.925

0.8215

(n.s)

kidney (n = 264)

0 (0%) A/A

6 (2.3%) G/A

0.6

0.2788-1.474

0.2915

(n.s)

thyroid (n = 173)

0 (0%) A/A

3 (1.7%) G/A

0.5

0.1528-1.549

0.2129

(n.s)

non-Hodgkin Lymphoma (n = 162)

0 (0%) A/A

6 (3.7%) G/A

1.1

0.4585-2.453

0.8909

(n.s)

breast (under 50 y) (n = 3318)

0 (0%) A/A

168 (5.1%) G/A

1.5

1.2764-1.832

0.002

 

melanoma (n = 471)

0 (0%) A/A

33 (7%) G/A

2.1

1.387-3.111

0.0003

 

pancreas (n = 210)

0 (0%) A/A

8 (3.8%) G/A

1.1

0.5246-2.273

0.8140

(n.s)